Pediatric Asthma Impairment and Risk Questionnaire: A Control Assessment for Children Aged 5 to 11 Years.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 40633688.
- Also identified by DOI 10.1016/j.jaip.2025.06.039.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Uncontrolled asthma in childhood is associated with exacerbations and impaired health-related quality of life. Commonly used control tools for children aged 5 to 11 years assess asthma symptoms but not exacerbations, potentially leading to overestimation of control and suboptimal management. This cross-sectional observational study aimed to validate the Pediatric Asthma Impairment and Risk Questionnaire (Peds-AIRQ), a novel control tool assessing symptom impairment and exacerbation risk. A total of 399 children aged 5 to 11 years with physician-diagnosed asthma were recruited from one primary care and seven specialty care sites across the United States. Parents and caregivers, with input from their child, answered 18 yes/no questions about asthma symptoms and exacerbations. Children were categorized as having well-controlled (WC), not well-controlled (NWC), or very poorly controlled (VPC) asthma according to a validation standard using Global Initiative for Asthma symptom control questions plus prior-year exacerbations. Items with the greatest ability to discriminate among control categories and cut points were determined through logistic regression analyses. Models yielded a Peds-AIRQ composed of five impairment-based and three risk-based questions. The Peds-AIRQ yielded areas under receiver-operating characteristic curves of 0.85 to differentiate WC versus NWC/VPC asthma and 0.83 to differentiate WC/NWC versus VPC asthma. Score cut points of 0 to 1, 2 to 4, and 5 to 8 yes responses were determined to best represent WC, NWC, and VPC asthma, respectively. The Peds-AIRQ is a validated numerical assessment tool for children aged 5 to 11 years that can be used at point-of-care to evaluate asthma control based on current symptoms and exacerbation history.
Medical subject headings
- Asthma